CytoSorbents Promotes Vincent J. Capponi to President

4 May 2020 - Yahoo News
CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically-ill and cardiac surgery patients around the world, and its Chief Executive Officer, Dr. Phillip Chan, ...
usx:ctso

---

CytoSorbents to Report Q1 2020 Operating and Financial Results

28 Apr 2020 - Yahoo News
CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, will report Q1 2020 financial results after the market close on Tuesday, ...
usx:ctso

---

Cytosorbents Appoints Dr. Efthymios N. Deliargyris, M.D., As Chief Medical Officer

27 Apr 2020 - Yahoo News
CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, today announced the appointment of Efthymios N. Deliargyris, MD, FACC, ...
usx:ctso

---

Development Update: U.S. FDA Grants Breakthrough Designation to CytoSorb for Removal of Ticagrelor During Cardiopulmonary Bypass in Emergent and Urgent Cardiothoracic Surgery

20 Apr 2020 - Yahoo News
CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically-ill and cardiac surgery patients around the world, announced that the U.S. Food and Drug Administration ...
usx:ctso

---

New Study Suggests CytoSorb Improves Clinical Outcomes in Pneumonia Patients With Septic Shock and Acute Respiratory Distress Syndrome (ARDS) on ECMO

15 Apr 2020 - Yahoo News
CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically-ill and cardiac surgery patients around the world, highlights a recently published study entitled, "Combined ...
usx:ctso

---

CytoSorbents Gains Emergency Authorization for Covid-19 Treatment

13 Apr 2020 - Yahoo News
The FDA says CytoSorbents' blood purification system 'may be effective' in fighting cytokine storms.
usx:ctso

---

CytoSorbents' stock jumps on FDA authorization for its device in COVID-19 patients

13 Apr 2020 - Yahoo News
Shares of CytoSorbents Corp. gained 28.7% in trading on Monday following a Food and Drug Administration announcement late on Friday that grants an emergency use authorization to the company's blood purification system for COVID-19 patients. An EUA is not an FDA approval; however, during the COVID-19 ...
usx:ctso

---

U.S. FDA Grants CytoSorb® Emergency Use Authorization for Use in Patients with COVID-19 Infection

13 Apr 2020 - Yahoo News
CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically-ill and cardiac surgery patients around the world, announced the United States Food and Drug Administration ...
usx:ctso

---

CytoSorbents CEO to Discuss COVID-19 Pandemic and its CytoSorb® Treatment of Cytokine Storm in Cowen COVID-19 Series Conference Call Today

3 Apr 2020 - Yahoo News
CytoSorbents Corporation (NASDAQ: CTSO) a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically-ill and cardiac surgery patients around the world, announced that its Chief Executive Officer, Dr. Phillip ...
usx:ctso

---

CytoSorb® Receives Marketing Approval in Mexico with Commercialization to Commence with Partner Fresenius Medical Care

31 Mar 2020 - Yahoo News
CytoSorbents Corporation (NASDAQ: CTSO) a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically-ill and cardiac surgery patients around the world, announced that its CytoSorb cytokine adsorber has been ...
usx:ctso

---